Abstract

The SYNTAX Score II (SSII) risk score was developed from the SYNTAX trial to predict 4-year mortality after left main (LM) or multivessel disease revascularization. SSII combines anatomic lesion data and selected clinical characteristics (age, sex, COPD, peripheral artery disease, LVEF, creatinine

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.